Readouts For TIGIT And Alzheimer’s Drugs Will Define Roche’s Year

Will Shape Growth Trajectory

 
• By Andrew McConaghie
  
Roche_Basel
Roche has more readouts this year and than any other European major pharma company. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip